“If we don’t leverage the power of innovation to transform how health services are provided and utilized, efforts to stop new HIV infections and AIDS-related deaths can reach a stalemate,” UNAIDS Executive Director Michel Sidibe writes in this opinion piece in the Huffington Post’s “Healthy Living” blog.
No Comments »
Filed under: Pharmacy News
A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo…
No Comments »
Filed under: Men's Health
A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo.
No Comments »
Filed under: Pharmacy News
Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial’s external [...]
No Comments »
Filed under: Pharmacy News
Breckenridge Pharmaceutical, Inc. announced today that it has finalized its agreement with Zhejiang Huahai Pharmaceuticals Co., Ltd. (Huahai) to market Nevirapine Tablets. Nevirapine 200mg Tablets are AB rated to Viramune a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS, which is marketed by Boehringer Ingelheim.
No Comments »
Filed under: Pharmacy News
An international team led by UC Davis researchers has found that mothers in sub-Saharan Africa could successfully follow a protocol for flash-heating breast milk to reduce transmission of human immunodeficiency virus (HIV) — the virus that causes AIDS — to their infants…
No Comments »
Filed under: Women's Health
African-Americans with HIV are much less likely to adhere to drug therapy than others with the disease, according to a University of Michigan study.
No Comments »
Filed under: Pharmacy News
In public comments submitted this week, a group of 14 leading HIV/AIDS and health organizations stated their support for Food and Drug Administration (FDA) approval of emtricitabine/ tenofovir disoproxil fumarate (TDF/FTC or Truvada) as pre-exposure prophylaxis (PrEP) to prevent HIV infection in adult men and women.
No Comments »
Filed under: Pharmacy News
Two separate posts in the Center for Global Health Policy’s “Science Speaks” blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday “about the Foundation’s treatment optimization activities,” writing, “According to Becker, the Foundation acknowledges that [...]
No Comments »
Filed under: Pharmacy News
In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms or their breastfeeding babies for 28 weeks proved safe and effective for preventing mother-to-child HIV transmission through breast milk.
No Comments »
Filed under: Pharmacy News
